Tau Protein is one of the most extensively studied proteins in neuroscience and Alzheimer's disease research. Under normal conditions, tau helps maintain the internal structure of neurons by supporting microtubules, which transport nutrients and cellular components throughout the nerve cell.
In Alzheimer's disease and certain other neurodegenerative disorders, abnormal forms of tau can accumulate inside neurons and form neurofibrillary tangles. These tangles are considered one of the hallmark pathological features of Alzheimer's disease.
The Tau Protein marker in the Alzheimer's LINX™ panel does not measure tau concentration in the blood or cerebrospinal fluid. Instead, it evaluates whether the immune system has developed antibodies against tau protein. Elevated immune reactivity may suggest that the immune system is recognizing tau-related structures as targets.
Researchers continue to investigate the relationship between immune activation, neuroinflammation, blood-brain barrier dysfunction, and neurodegenerative disease. Immune reactivity to tau may represent one piece of a broader pattern of neurological immune responses measured by the Alzheimer's LINX™ panel.
A positive result does not mean a person has Alzheimer's disease, dementia, or ongoing neuronal damage. Likewise, a normal result does not exclude neurological disease. Results are best interpreted in the context of other Alzheimer's LINX™ biomarkers, symptoms, cognitive assessments, imaging studies, and established neurological biomarkers.
Tau Protein
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.